Renée Aguiar-Lucander
Vorstandsvorsitzender bei CALLIDITAS THERAPEUTICS AB
Vermögen: 6 Mio $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Renée Aguiar-Lucander
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 28 | |
Simparel, Inc.
 Simparel, Inc. Miscellaneous Commercial ServicesCommercial Services Simparel, Inc. provides global supply chain management solutions. It provides apparel manufacturing software solutions. The firm offers enterprise resource planning, product lifecycle management, supply chain management, warehouse management system, mobile wholesale solution, electronic data interchange, manufacturing, material resource planning and financial management solutions. The company was founded in 2007 and is headquartered in New York, NY.
8
| Private Company | Miscellaneous Commercial Services | 8 |
Egalet Ltd.
 Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Exenta, Inc.
 Exenta, Inc. Packaged SoftwareTechnology Services Exenta, Inc. provides information technology and services. It offers fashion and soft goods ERP software, product lifecycle management, supply chain management, shop floor control (mobile), warehouse management, enterprise resource planning (ERP), electronic data interchange, Mfg and materials planning services. The company is headquartered in New York, NY.
4
| Subsidiary | Packaged Software | 4 |
Lehman Brothers, Inc. (Milan Branch)
3
| Extinct | Investment Banks/Brokers | 3 |
Egalet A/S
 Egalet A/S Pharmaceuticals: MajorHealth Technology Egalet A/S operates as a specialty pharmaceuticals company. It develops opioid formulations for pain management based on abuse deterrent prolonged release erosion matrix technology in Denmark. The company develops prolonged and delayed release therapeutics for chronic pain management, including Parvulet, a delivery platform for facilitating dispensing of oral doses to pediatric and geriatric patient segments; and Egalet morphine. The company was founded by Jan Quistgaard in 1995 and is headquartered in Vaerloese, Denmark.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Renée Aguiar-Lucander
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Treasurer Director/Board Member | |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Morphotek, Inc.
 Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Prestwick Pharmaceuticals, Inc.
 Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| RENEURON GROUP PLC | Pharmaceuticals: Major | Chief Executive Officer | |
Topaz Pharmaceuticals, Inc.
 Topaz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Topaz Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on developing and commercializing treatments for the pediatric and dermatology markets. Its lead investigational product is a topical cream formulation of ivermectin which is under development. The firm provides medicines for the treatment of head lice, acne and infections, as well as vaccines against childhood diseases. The company was founded by Donald P. Beeman and Nicholas U. Spring in 2005 and is headquartered in Horsham, PA. | Pharmaceuticals: Major | Chief Executive Officer | |
Copenhagen Capacity
 Copenhagen Capacity Financial ConglomeratesFinance Copenhagen Capacity provides investment promotion and economic development services. The private company is based in Copenhagen, Denmark. Asbjørn Overgaard Christiansen has been the CEO of the Danish company since 2020. | Financial Conglomerates | Director/Board Member | |
| PCI BIOTECH HOLDING ASA | Biotechnology | Director/Board Member | |
| ZYLA LIFE SCIENCES | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Boston College | College/University | Undergraduate Degree | |
| Georgia State University | College/University | Graduate Degree Masters Business Admin | |
| Hofstra University | College/University | Undergraduate Degree | |
| MEDCAP AB | Medical Specialties | Director/Board Member Chairman | |
| University of Uppsala | College/University | Graduate Degree Masters Business Admin Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| WEIFA ASA | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| University of Lund | College/University | Graduate Degree Graduate Degree | |
| University of Oslo | College/University | Graduate Degree Doctorate Degree | |
| University of Copenhagen | College/University | Graduate Degree Doctorate Degree | |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Miscellaneous Commercial Services | Director/Board Member | |
| VIROGATES A/S | Medical Specialties | Chief Executive Officer | |
Novartis UK Ltd.
 Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom. | Pharmaceuticals: Major | Chief Operating Officer | |
| UCB Pharma AS | Corporate Officer/Principal | ||
| BERGENBIO ASA | Pharmaceuticals: Major | Corporate Officer/Principal Chairman | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| Instituto de Estudios Superiores de la Empresa | College/University | Masters Business Admin | |
| Horse Power For Life | Director/Board Member | ||
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
| PARATEK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Palma Biotech S.L. | Founder | ||
| SEDANA MEDICAL AB | Medical Specialties | Director/Board Member Chairman Director/Board Member | |
Swevet Holding AB
 Swevet Holding AB Miscellaneous Commercial ServicesCommercial Services Swevet Holding AB is a supplier of medicines and consumables for animal care and veterinary operations. The private company is based in Sjobo, Sweden. The Swedish company has a wide range of products and offers fast delivery services. Swevet has extensive experience in the field, which enables it to provide safe advice on purchasing veterinary equipment and taking care of it. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| GENKYOTEX SA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Nefecon AB
 Nefecon AB Pharmaceuticals: MajorHealth Technology Part of Calliditas Therapeutics AB, Nefecon AB is a pharmaceutical company based in Stockholm, Sweden. The Swedish company has developed a patented oral, delayed release formulation of budesonide called nefecon, which is designed to target mucosal B-cells present in the ileum where the disease originates, as per the predominant pathogenesis models. Nefecon is derived from the targit technology, which allows for the substance to pass through the stomach and intestine without being absorbed, and to be released in a pulse-like fashion only when it reaches the lower small intestine. The company has completed a large phase 2b trial, which showed that the combination of dose and optimized release profile is required to be effective in patients with IgA nephropathy. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Busulipo AB
 Busulipo AB Pharmaceuticals: MajorHealth Technology Busulipo AB is a Swedish company that manufactures and wholesales pharmaceutical and medical technology products. The private company is based in Stockholm, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| Ingeniørsystem A/S | Director/Board Member | ||
| P.V. Fonden | Director/Board Member | ||
Pluvia AS
 Pluvia AS Miscellaneous Commercial ServicesCommercial Services Pluvia AS operates as a research-based pharmaceutical company. The company is headquartered in Bergen, Norway. | Miscellaneous Commercial Services | Director/Board Member | |
J&J Future Invest AS
 J&J Future Invest AS Real Estate DevelopmentFinance J & J Future Invest AS is a Norwegian company that operates a real estate agency. | Real Estate Development | Corporate Officer/Principal | |
| Pharmalink Nordic AB | Corporate Officer/Principal Director/Board Member | ||
| Jakob Knudsen Enkeltmandsvirksomhed | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 19 |
| Schweden | 14 |
| Norwegen | 9 |
| Dänemark | 7 |
| Vereinigtes Königreich | 3 |
Sektoral
| Health Technology | 29 |
| Consumer Services | 10 |
| Commercial Services | 5 |
| Finance | 3 |
Operativ
| Director/Board Member | 280 |
| Corporate Officer/Principal | 87 |
| Independent Dir/Board Member | 73 |
| Chairman | 62 |
| Chief Executive Officer | 26 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Thomas Lennart Eklund | 57 |
| Jean-Francois Formela | 47 |
| Bengt Åke Julander | 36 |
| Francesco de Rubertis | 36 |
| Elmar Schnee | 31 |
| Ann-Tove Kongsnes | 24 |
| Fred Driscoll | 21 |
| Hilde Furberg | 21 |
| Rosa Cipriotti | 21 |
| Paul David Goldenheim | 18 |
| Robert Radie | 18 |
| Henrik Stenqvist | 16 |
| Andreas Segerros | 16 |
| Diane Parks | 14 |
| Olav Hellebø | 13 |
- Börse
- Insiders
- Renée Aguiar-Lucander
- Unternehmensverbindungen
